Health News

Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center announced key findings from a Phase I clinical trial of Cornerstone’s first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia (AML)…

Read more

Filed under: Pharmacy News
Tags: cancer, Drug, leukemia, Pharmacy

Related posts

• Vorinostat in addition to chemotherapy drugs improves remission rates in AML patients (0)
  Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology. Read more [tags] Pharmacy News [/tags]
  
  
• Tigecycline antibiotic shows promise against leukemia (0)
  Clinician-scientists in the Princess Margaret Cancer Program have found a promising approach to treating leukemia, using an old drug in a new way. Read more [tags] Pharmacy News [/tags]
  
  
• Taxoxifen combined with dasatinib reverses chemo-resistance in breast cancer cells (0)
  Taking a leukemia chemotherapy drug may help breast cancer patients who don't respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests. Read more [tags] Pharmacy News [/tags]
  
  
• Supply of childhood leukemia drug nearly exhausted (0)
  A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice. Read more [tags] Pharmacy News [/tags]
  
  
• Sunesis Pharmaceuticals Provides Year-End Clinical Update On Voreloxin (0)
  Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) provided a clinical update on voreloxin, its novel investigational drug candidate currently being developed in Phase 2 trials for acute myeloid leukemia (AML) and ovarian cancer. The clinical update coincides with the company's attendance at the 27th Annual JP Morgan Healthcare Conference in San Francisco. Read more [tags] Pharmacy News [/tags]